Procter & Gamble Looks Ahead to Merck KGaA Acquisition – Drug for nerve pain boosts high for opioid abusers. (866) 348-2889
Procter & Gamble (P&G) announced last month that it has agreed to acquire Merck KGaA’s consumer health unit for 3.4 billion euros or about $4.2 billion.1
The purchase is a sign of the company’s commitment to be a leader in the consumer health market, according to Velvet Gogol Bennett, P&G’s global health care communications director.
“The acquisition of Merck KGaA Consumer Health Care enables P&G to improve our PHC geographic scale, brand portfolio, and category footprint in all of our regions and in the vast majority of the worlds’ top 15 OTC markets by adding a fast-growing portfolio of differentiated, physician-supported, multi-region brands,” she said in an interview. “It also provides us with strong health care commercial and supply capabilities, deep technical mastery and proven consumer health care leadership that will complement our own OTC capabilities, brands, and leadership.”